Wednesday, November 18, 2015 4:31:45 PM
This time I was struck by the nature and quality of the analyst questions. Based on the questions they ask it seems clear they don't understand how the Sandoz/NVS collaborations work.
The GS analyst for example is asking about channel stocking and inventory level. Same with the Stifel analyst asking about manufacturing, stocking, and drawdown.
Had they been around for Enox they would know all sales and manufacturing is handled by Sandoz and all info regarding that is only released by Novartis quarterly.
Has anyone else here noticed that it seems like the analysts don't really understand MNTA?
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM